FDA Approves Zavegepant Nasal Spray for Acute Migraine ...Middle East

The third-generation CGRP receptor agonist provided relief from acute migraine as soon as 15 minutes after intranasal dosing in a pivotal phase 3 trial. FDA Approvals

Hence then, the article about fda approves zavegepant nasal spray for acute migraine was published today ( Tuesday 14/03/2023 - 11:56 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Zavegepant Nasal Spray for Acute Migraine )

Also on site :

• Lisa Kudrow Gets Brutally Honest About ‘Friends’ Fame
• Iran strikes fully loaded Kuwaiti oil tanker at Dubai port; spill risk flagged
• Rubio says NATO must be re-examined after Spain blocks US operation on Iran